|
Kalyuzhin O.V.
Aterixen® (ХС221GI) as an effective and safe remedy for treatment of COVID-19, influenza and other acute respiratory viral infections treatment: Review of clinical studies
|
№2 / 2024
|
|
Mineeva E.S., Demko I.V., Sobko E.A., Kruglova O.S., Kudryavtsev Ya.I.
Peculiarities of clinical and radiological parameters, indexes of systemic inflammation and immune status in vaccinated patients with COVID-19
|
№10 / 2023
|
|
Abysov A.S., Kichigin V.A., Savvateeva O.A.
COVID-19 pandemic and the state of kidney function
|
№7 / 2023
|
|
Kabysh S.S., Prokopenko S.V., Abdullayev M.B.
Cognitive disorders in patients during the acute period of coronavirus infection complicated by pneumonia and during the acute period of ischemic stroke: Similarities and differences
|
№5 / 2023
|
|
Semenova T.N., Grigoryeva V.N., Zanozina O.V., Sukhanov S.A.
Cognitive disorders in patients with hypertonic cerebral microangiopathy associated with type 2 diabetes mellitus and COVID-19
|
№5 / 2023
|
|
Mashin V.V., Belova L.A., Dudikov E.M., Slesareva E.V., Dolgova D.R., Nikishin K.E., Lyalchenko Yu.A.
Damage of nervous system in COVID-19: Neuropsychological syndromes, histological data
|
№5 / 2023
|
|
Mashin V.V., Dolgova D.R., Belova L.A., Kotova E. Yu., Kruglova L.R., Statenina A.P., Kozin A.A., Israfilova R.R., Martynova D.K.
Diagnostic and prognostic significance of endothelial dysfunction biochemical markers in patients with discirculatory encephalopathy after COVID-19
|
№5 / 2023
|
|
Ponomareva E.Yu., Sedov D.S.
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment
|
№4 / 2023
|
|
Rebrov A.P., Tyapkina M.A., Ordyakova A.A., Yupatov V.D., Kosheleva N.A., Basov I.V.
Patients with cardiovascular diseases and NSAIDs intake: Is there a real problem today?
|
№4 / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
Русский
